AC
MGNX icon

Amia Capital’s MacroGenics MGNX Stock Holding History

Amia Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,131
Closed -$608K – 20
2020
Q3 		$608K Sell
24,131
-1,272
-5% -$34.7K 0.71% 19
2020
Q2 		$709K Sell
25,403
-13,986
-36% -$243K 0.58% 18
2020
Q1 		$229K Sell
39,389
-5,259
-12% -$47.8K 0.2% 33
2019
Q4 		$486K Buy
+44,648
New +$442K 0.14% 33

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Amia Capital's MGNX Position: Q4 2020 in Review

Amia Capital sold out of MacroGenics (MGNX) in Q4 2020, closing a stake of 24,131 shares — an estimated $608K sold.

Amia Capital first reported a position in MGNX in Q4 2019 and held it in 4 quarters. The position peaked at $709K in Q2 2020. 147 funds tracked by Wall St. Rank hold MGNX as of Q4 2020.

  • Amia Capital reported no remaining MacroGenics position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 24,131 MacroGenics shares in Q4 2020, an estimated $608K.
  • Amia Capital first reported a position in MacroGenics in Q4 2019 and held it in 4 quarters.
  • Amia Capital's MacroGenics position peaked at $709K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held MacroGenics as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.